Healthcare and Pharmaceuticals industry

Durvalumab Market 2020 By Manufacturers, Regions, Type, And Application, Forecast To 2026




 

Impact Analysis of Covid-19

The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Summary

The global Durvalumab Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019. 

The Durvalumab Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Durvalumab Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The Key Manufacturers covered in this Report:-

  • Medimmune (AstraZeneca)
  • ...

By the Product Type, the market is primarily segmented into:

  • 2.4mL Injection
  • 10mL Injection

By Applications, the market is segmented into:

  • Locally Advanced Urothelial Carcinoma
  • Metastatic Urothelial Carcinoma
  • Other

The Report covers the following Regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Objective of the Durvalumab Market Report:

  • To assess the size of the market by value and volume
  • Analyze the Durvalumab Market in terms of regions and major countries
  • Highlight recent developments and trends in the market
  • Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
  • Determine share of the Durvalumab Market in terms of various segments such as by product type, application, and end-user
  • Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
  • Discuss major factors that impact growth of the Durvalumab Market

The Durvalumab Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Durvalumab Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders:

  • Material suppliers/wholesalers
  • Market Distributors/traders
  • Regulatory bodies
  • Research organizations, and consulting firms
  • Commercial research & developments (R&D)
  • Trade associations and industry bodies
  • Importers and exporters
  • End-use industries

Available Customizations:

Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Table of Contents

Executive Summary
1 Durvalumab Market Overview
1.1 Product Overview and Scope of Durvalumab
1.2 Durvalumab Segment by Type
1.2.1 Global Durvalumab Production Growth Rate Comparison by Type (2014-2025)
1.2.2 2.4mL Injection
1.2.3 10mL Injection
1.3 Durvalumab Segment by Application
1.3.1 Durvalumab Consumption Comparison by Application (2014-2025)
1.3.2 Locally Advanced Urothelial Carcinoma
1.3.3 Metastatic Urothelial Carcinoma
1.3.4 Other
1.4 Global Durvalumab Market by Region
1.4.1 Global Durvalumab Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Durvalumab Market Size
1.5.1 Global Durvalumab Revenue (2014-2025)
1.5.2 Global Durvalumab Production (2014-2025)

2 Global Durvalumab Market Competition by Manufacturers
2.1 Global Durvalumab Production Market Share by Manufacturers (2014-2019)
2.2 Global Durvalumab Revenue Share by Manufacturers (2014-2019)
2.3 Global Durvalumab Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Durvalumab Production Sites, Area Served, Product Types
2.5 Durvalumab Market Competitive Situation and Trends
2.5.1 Durvalumab Market Concentration Rate
2.5.2 Durvalumab Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Durvalumab Production Market Share by Regions
3.1 Global Durvalumab Production Market Share by Regions
3.2 Global Durvalumab Revenue Market Share by Regions (2014-2019)
3.3 Global Durvalumab Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Durvalumab Production
3.4.1 North America Durvalumab Production Growth Rate (2014-2019)
3.4.2 North America Durvalumab Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Durvalumab Production
3.5.1 Europe Durvalumab Production Growth Rate (2014-2019)
3.5.2 Europe Durvalumab Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Durvalumab Production
3.6.1 China Durvalumab Production Growth Rate (2014-2019)
3.6.2 China Durvalumab Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Durvalumab Production
3.7.1 Japan Durvalumab Production Growth Rate (2014-2019)
3.7.2 Japan Durvalumab Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Durvalumab Consumption by Regions
4.1 Global Durvalumab Consumption by Regions
4.2 North America Durvalumab Consumption (2014-2019)
4.3 Europe Durvalumab Consumption (2014-2019)
4.4 China Durvalumab Consumption (2014-2019)
4.5 Japan Durvalumab Consumption (2014-2019)

5 Global Durvalumab Production, Revenue, Price Trend by Type
5.1 Global Durvalumab Production Market Share by Type (2014-2019)
5.2 Global Durvalumab Revenue Market Share by Type (2014-2019)
5.3 Global Durvalumab Price by Type (2014-2019)
5.4 Global Durvalumab Production Growth by Type (2014-2019)

6 Global Durvalumab Market Analysis by Applications
6.1 Global Durvalumab Consumption Market Share by Application (2014-2019)
6.2 Global Durvalumab Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Durvalumab Business
7.1 Medimmune (AstraZeneca)
7.1.1 Medimmune (AstraZeneca) Durvalumab Production Sites and Area Served
7.1.2 Durvalumab Product Introduction, Application and Specification
7.1.3 Medimmune (AstraZeneca) Durvalumab Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served

8 Durvalumab Manufacturing Cost Analysis
8.1 Durvalumab Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Durvalumab
8.4 Durvalumab Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Durvalumab Distributors List
9.3 Durvalumab Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Durvalumab Market Forecast
11.1 Global Durvalumab Production, Revenue Forecast
11.1.1 Global Durvalumab Production Growth Rate Forecast (2019-2025)
11.1.2 Global Durvalumab Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Durvalumab Price and Trend Forecast (2019-2025)
11.2 Global Durvalumab Production Forecast by Regions (2019-2025)
11.2.1 North America Durvalumab Production, Revenue Forecast (2019-2025)
11.2.2 Europe Durvalumab Production, Revenue Forecast (2019-2025)
11.2.3 China Durvalumab Production, Revenue Forecast (2019-2025)
11.2.4 Japan Durvalumab Production, Revenue Forecast (2019-2025)
11.3 Global Durvalumab Consumption Forecast by Regions (2019-2025)
11.3.1 North America Durvalumab Consumption Forecast (2019-2025)
11.3.2 Europe Durvalumab Consumption Forecast (2019-2025)
11.3.3 China Durvalumab Consumption Forecast (2019-2025)
11.3.4 Japan Durvalumab Consumption Forecast (2019-2025)
11.4 Global Durvalumab Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Durvalumab Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Table
List of Tables and Figures

Figure Picture of Durvalumab
Table Global Durvalumab Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Durvalumab Production Market Share by Types in 2018
Figure 2.4mL Injection Product Picture
Table 2.4mL Injection Major Manufacturers
Figure 10mL Injection Product Picture
Table 10mL Injection Major Manufacturers
Table Global Durvalumab Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Durvalumab Consumption Market Share by Applications in 2018
Figure Locally Advanced Urothelial Carcinoma
Figure Metastatic Urothelial Carcinoma
Figure Other
Table Durvalumab Market Size (Million US$) Comparison by Regions (2014-2025)
Figure North America Durvalumab Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Durvalumab Revenue (Million USD) and Growth Rate (2014-2025)
Figure China Durvalumab Revenue (Million USD) and Growth Rate (2014-2025)
Figure Japan Durvalumab Revenue (Million USD) and Growth Rate (2014-2025)
Figure Global Durvalumab Revenue (Million USD) (2014-2025)
Figure Global Durvalumab Production (K Pcs) (2014-2025)
Table Global Durvalumab Production (K Pcs) of Key Manufacturers (2014-2019)
Table Global Durvalumab Production Share by Manufacturers (2014-2019)
Figure Durvalumab Production Share by Manufacturers in 2018
Table Global Durvalumab Revenue (Million USD) by Manufacturers (2014-2019)
Table Global Durvalumab Revenue Share by Manufacturers (2014-2019)
Figure Global Durvalumab Revenue Share by Manufacturers in 2018
Table Global Market Durvalumab Average Price (USD/Pcs) of Key Manufacturers (2014-2019)
Figure Global Market Durvalumab Average Price (USD/Pcs) of Key Manufacturers in 2018
Table Manufacturers Durvalumab Production Sites and Area Served
Table Manufacturers Durvalumab Product Types
Figure Durvalumab Market Share of Top 5 Manufacturers
Figure Durvalumab Market Share of Top 10 Manufacturers
Table Global Durvalumab Production (K Pcs) by Region (2014-2019)
Table Global Durvalumab Production Market Share by Region (2014-2019)
Figure Global Durvalumab Production Market Share by Region (2014-2019)
Figure Global Durvalumab Production Market Share by Region in 2018
Table Global Durvalumab Revenue (Million USD) by Region (2014-2019)
Table Global Durvalumab Revenue Market Share by Region (2014-2019)
Figure Global Durvalumab Revenue Market Share by Region (2014-2019)
Figure Global Durvalumab Revenue Market Share by Region in 2018
Figure Global Durvalumab Production (K Pcs) Growth Rate (2014-2019)
Table Global Durvalumab Production (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure North America Durvalumab Production (K Pcs) Growth Rate (2014-2019)
Table North America Durvalumab Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Europe Durvalumab Production (K Pcs) Growth Rate (2014-2019)
Table Europe Durvalumab Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure China Durvalumab Production (K Pcs) Growth Rate (2014-2019)
Table China Durvalumab Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Japan Durvalumab Production (K Pcs) Growth Rate (2014-2019)
Table Japan Durvalumab Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Global Durvalumab Consumption (K Pcs) Market by Region (2014-2019)
Table Global Durvalumab Consumption Market Share by Region (2014-2019)
Figure Global Durvalumab Consumption Market Share by Region (2014-2019)
Figure Global Durvalumab Consumption Market Share by Region in 2018
Figure North America Durvalumab Consumption Growth Rate (2014-2019) (K Pcs)
Figure Europe Durvalumab Consumption Growth Rate (2014-2019) (K Pcs)
Figure China Durvalumab Consumption Growth Rate (2014-2019) (K Pcs)
Figure Japan Durvalumab Consumption Growth Rate (2014-2019) (K Pcs)
Table Global Durvalumab Production (K Pcs) by Type (2014-2019)
Table Global Durvalumab Production Share by Type (2014-2019)
Figure Production Market Share of Durvalumab by Type (2014-2019)
Figure Production Market Share of Durvalumab by Type in 2018
Table Global Durvalumab Revenue (Million USD) by Type (2014-2019)
Table Global Durvalumab Revenue Share by Type (2014-2019)
Figure Revenue Share of Durvalumab by Type (2014-2019)
Figure Revenue Market Share of Durvalumab by Type in 2018
Table Global Durvalumab Price (USD/Pcs) by Type (2014-2019)
Figure Global Durvalumab Production Growth by Type (2014-2019) (K Pcs)
Table Global Durvalumab Consumption (K Pcs) by Application (2014-2019)
Table Global Durvalumab Consumption Market Share by Application (2014-2019)
Figure Global Durvalumab Consumption Market Share by Applications (2014-2019)
Figure Global Durvalumab Consumption Market Share by Application in 2018
Table Global Durvalumab Consumption Growth Rate by Application (2014-2019)
Figure Global Durvalumab Consumption Growth Rate by Application (2014-2019)
Table Medimmune (AstraZeneca) Durvalumab Production Sites and Area Served
Table Medimmune (AstraZeneca) Product Introduction, Application and Specification
Table Medimmune (AstraZeneca) Durvalumab Production (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Medimmune (AstraZeneca) Durvalumab Production Growth Rate (2014-2019)
Figure Medimmune (AstraZeneca) Durvalumab Production Market Share (2014-2019)
Figure Medimmune (AstraZeneca) Durvalumab Revenue Market Share (2014-2019)
Table Medimmune (AstraZeneca) Main Business and Markets Served
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Durvalumab
Figure Manufacturing Process Analysis of Durvalumab
Figure Durvalumab Industrial Chain Analysis
Table Durvalumab Distributors List
Table Durvalumab Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Figure Global Durvalumab Production (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Global Durvalumab Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Global Durvalumab Price and Trend Forecast (2019-2025)
Table Global Durvalumab Production (K Pcs) Forecast by Region (2019-2025)
Figure Global Durvalumab Production Market Share Forecast by Region (2019-2025)
Figure North America Durvalumab Production (K Pcs) and Growth Rate Forecast (2019-2025)
Figure North America Durvalumab Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Europe Durvalumab Production (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Europe Durvalumab Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure China Durvalumab Production (K Pcs) and Growth Rate Forecast (2019-2025)
Figure China Durvalumab Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Figure Japan Durvalumab Production (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Japan Durvalumab Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Durvalumab Consumption (K Pcs) Forecast by Regions (2019-2025)
Figure Global Durvalumab Consumption Market Share Forecast by Regions (2019-2025)
Figure North America Durvalumab Consumption (K Pcs) Growth Rate Forecast (2019-2025)
Figure Europe Durvalumab Consumption (K Pcs) Growth Rate Forecast (2019-2025)
Figure China Durvalumab Consumption (K Pcs) Growth Rate Forecast (2019-2025)
Figure Japan Durvalumab Consumption (K Pcs) Growth Rate Forecast (2019-2025)
Table Global Durvalumab Production (K Pcs) Forecast by Type (2019-2025)
Figure Global Durvalumab Production (K Pcs) Forecast by Type (2019-2025)
Table Global Durvalumab Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Durvalumab Revenue Market Share Forecast by Type (2019-2025)
Table Global Durvalumab Price (USD/Pcs) Forecast by Type (2019-2025)
Table Global Durvalumab Consumption (K Pcs) Forecast by Application (2019-2025)
Figure Global Durvalumab Consumption Forecast by Application (2019-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
 



Contact Us

  +1-415-871-0703


Drop Us an email at

[email protected]

Frequently Asked Questions

The report efficiently evaluates the market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Mn Units).
Market is segmented by Product Types, Drug Class, Indication, Applications, Services Types, End-users, Distribution channel, and Regions.
The report presents the current market size, and market forecast, market opportunities, key drivers and restraints, pipeline Analysis, incidence rate, epidemiology analysis, prevalence rate, regulatory scenario, industry trend, PESTLE analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing initiatives, pricing analysis, export-import analysis, trade analysis, competitive landscape which help businesses in decision making. The analysis data is based on current and historical market trends which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any organization to gain insight into specific business sector, aligned with specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.

Testimonials

Get In Touch

In search of customized market research solution? We are here to help you. Contact us.